ScanGrants is a public service listing of grants and other funding types to support health research, programs and scholarship.
5 funding opportunities found in this category. Change the order of results:
Lowest Award to Highest
Highest Award to Lowest
Call for Applications: 2014 NASPGHAN/NASPGHAN Foundation Medical Student Mentored Summer Research Program
Purpose: To develop a program at multiple sites throughout the U.S. and Canada through which medical students can have 10-week research experiences under the mentorship of basic or clinical scientists with a research focus in pediatric gastroenterology, hepatology, or nutrition.
Candidates: Students in good standing at accredited medical schools in the U.S. and Canada who have completed their first year of medical training who are seeking a research experience between the first and second years of medical school.
Application forms are available at the NASPGHAN web site (www.naspghan.org). The deadline for application is March 14, 2014.
Mentors: M.D., Ph.D., or M.D./Ph.D. members of NASPGHAN with a track record of independent peer-reviewed research, previous success with trainees (students, residents, or fellows), and a commitment to provide the necessary resources to make the experience meaningful for the student are eligible to serve as mentors. Mentors will apply for consideration with documentation of productivity (CV), grant support sufficient to support the research activities of the summer student, and previous experience with trainees. The Advisory Committee will approve all mentors. Members of the Training and Research Committees are available to assist students in finding suitable mentors.
Program: Each mentor will develop a program for the student that includes didactic training regarding study design, methods of data analysis, and ethics in research (e.g. human subject protection and animal subject protection). A minimum of 4 hours of didactic course work is required. The mentor should have scheduled meetings with the student to assess progress including an interim presentation of results at the midpoint of the studentship. The mentor/student are required to submit a brief (one page, single spaced) interim report of progress in July and a final report of accomplishments in September to the Advisory Committee. The final report should take the form of a research abstract. Provided that the Advisory Committee finds that the work meets the standards of the program, each student may attend the NASPGHAN Annual Meeting and Postgraduate Course, October 23-25, 2014 in Atlanta, GA, and present the research in poster format.
Stipends of $4000 for at least a 10 week experience will be provided to each student.
NASPGHAN/NASPGHAN Foundation will support up to 4 students this year through this program.
Call for Applications: American Gastroenterological Association JAK-Inflammatory Bowel Disease Research Grant
Duration: Two years
Deadline: June 6, 2014
Start Date: Oct. 1, 2014
This award provides up to $100,000 per year for two years (total $200,000) to an investigator interested in studying the role of Janus kinase (JAK) pathways in the pathophysiology and immunology of inflammatory bowel disease (IBD).
The overall objective of this grant is to encourage innovative research into the role that Janus kinase pathways play in the pathophysiology and immunology of inflammatory bowel disease with the goal of ultimately improving IBD treatment.
• Candidates for this award must hold an MD, PhD or equivalent degree (e.g., MB, ChB, MBBS, DO) and a full-time faculty position at a nonprofit institution. There are no geographic or applicant age restrictions.
• AGA membership is not required to apply for this grant. However, if the grant recipient is not a member, he/she is encouraged to submit an application for membership
• Applications involving interventional studies of a Pfizer product are out of scope and will not be accepted.
• The grant will be paid directly to the recipient’s institution by Pfizer. The proposed budget may not exceed $100,000/year for two years inclusive of all costs. Funding will commence October 2014.
•The grant recipient will be responsible for providing Pfizer with interim and final scientific progress reports.
However, ownership of the study data rests with the investigator and his/her institution. Submission of the results to Gastroenterology or other refereed scientific journal is strongly encouraged. All publications, presentations and abstracts arising from work funded by this grant must acknowledge funding from Pfizer.
The recipient will be selected based on the following criteria: significance and implications of the research to the treatment of IBD, innovation, approach, the applicant’s research environment, and evidence of institutional commitment.
A selection committee comprised of members of the AGA Research Awards Panel will review the proposals and select the award recipient. The Panel has sole responsibility for selecting the grant recipient.
The application deadline is June 6, 2014. Submission instructions will be posted no later than Feb. 28.
Funding for this grant is provided by Pfizer Inc, New York, NY.
Call for Applications: American Gastroenterological Association Microbiome Junior Investigator Research Award
Eligibility: Applicants who completed clinical training or received their final research degree in 2007 or later.
This award provides $30,000 per year for up to two years to junior investigators engaged in research related to the gut microbiome. Supported research may include basic, translational, clinical or health services investigation.
The overall goal of the AGA research awards program is to enable investigators, especially those in the early stages of their careers, to develop and maintain independent and productive research programs in digestive diseases.
The specific objective of this award is to encourage and facilitate innovative research into relationships between the gut microbiome and functioning of the digestive system in health and disease.
• Applicants for this award must hold an MD, PhD or equivalent degree (e.g., MB, ChB, MBBS or DO) and a full-time faculty position at a North American educational institution as of June 1, 2014.
• Applicants must be in the early phase of their careers: clinicians who completed clinical training and investigators who received their final research degree no more than seven (7) years before the application due date.
• Preference will be given to applicants who have not previously received R01 or similar major research awards from the NIH or other funding agencies but recipients of such awards are eligible for funding under this mechanism.
• The length of appropriately documented parental leave(s) of absence will not count toward the seven-year eligibility criterion. Exceptional circumstances may also be considered.
• Women and members of underrepresented minorities are strongly encouraged to apply.
• Recipients of this award must be full members of the AGA. Applicants who are not AGA members at the time of application must apply for and be accepted as members before funding will be released.
• Institutional indirect (facilities and administration) costs are not allowed. Upon notification of selection for this award, the principal investigator must submit documentation of approval from the appropriate institutional committee(s) for use of human subjects and/or animals. If such approval is not necessary, the recipient must submit a written explanation.
• The principal investigator must submit a scientific progress report and the recipient institution must submit a financial statement by January 31, 2015. Second year funding is contingent upon submission and review of this documentation. Within 60 days of completion or other termination of this award, a concise summary of the results of the research that it supported must be submitted to the AGA Research Foundation.
• All publications, presentations and abstracts arising from work supported by this award must acknowledge support of the AGA Microbiome Junior Investigator Research Award.
• It is expected that a manuscript describing studies performed under this award will be submitted to Gastroenterology or Clinical Gastroenterology and Hepatology.
• The recipient of this award will be recognized at the Researcher Recognition Celebration during DDW. The recipient and his/her sponsor will be expected to attend.
There must be a strong commitment from the candidate’s institution, ensuring that the applicant has adequate protected time, research space, and other supporting facilities and resources to enable successful completion of the proposed research. This commitment must be outlined in a letter from the candidate’s division chief or department chair. The letter must certify the amount of protected time and the nature of other resources that will be available to the applicant upon receipt of the award.
The recipient will be selected based on the following criteria:
• significance of the proposed research and implication for preventing or treating disease.
• scientific approach.
• institutional environment and support.
• applicant potential and commitment.
Members of the AGA Institute Research Awards Panel will review all submitted proposals and select the award recipient. Funding will begin on Oct. 1, 2014.
The application deadline is June 6, 2014. The completed application, letters of support and commitment and other documents must be combined and submitted as a single PDF document. The title of the document must include only the applicant’s last name and first initial and be sent by email to email@example.com. Hard copies will not be accepted.
Please direct all questions to the senior research awards manager at 301-222-4012 or firstname.lastname@example.org.
Funding for the AGA Microbiome Junior Investigator Award has been provided through a grant from Danone to the AGA Institute.
Call for Applications: American Gastroenterological Association-Aptalis Research Award in Pancreatic Disease
Eligibility: Young Investigators
This award provides $50,000 per year for two years (total $100,000) to young investigators, instructors, research associates or equivalents interested in the function and disorders of the exocrine pancreas. Research topics suitable for funding under this grant include but are not limited to: pancreatitis, pancreatic cancer, pancreatic insufficiency, the gut microbiome-pancreas relationship, pancreatic disease epidemiology or genetics (excluding diabetes), and pancreatic disease biomarkers.
The overall objective of this career development award is to encourage and support research into exocrine pancreatic disorders by helping to sustain the careers of young investigators with an interest in pancreatic disease.
• Candidates for this award must hold an MD, PhD or equivalent degree (e.g., MB, ChB, MBBS, DO) and a full-time faculty position at a North American institution by June 1, 2014.
• AGA membership is required at the time of application submission. Please visit the membership page or call 301-654-2055, extension 651, for membership information.
• The award is intended to support young faculty (not fellows) who have demonstrated exceptional promise and have some record of accomplishment in research. Candidates should be in the beginning years of their careers; therefore, established investigators are not appropriate candidates.
• MD applicants: no more than seven years shall have elapsed following the completion of clinical training (GI fellowship or its equivalent) and the start date of this award.
• PhD applicants: no more than seven years shall have elapsed following the awarding of a PhD and the start date of this award.
• Women and underrepresented minority applicants are strongly encouraged to apply; these applications in particular will receive the review committee’s full consideration.
• An appropriately documented parental leave of absence will not be counted toward the above noted seven-year eligibility criteria. Exceptional circumstances may also be considered.
• All submissions must be relevant to diagnosing, treating or researching the functions or diseases of the exocrine pancreas.
• At the time of application submission, candidates may not hold or have held an NIH R01, R29, R21, K08, K23, Veterans Affairs Career Development Award or any award with similar objectives from non-federal sources (such as the American Liver Foundation, Burroughs Wellcome Fund, Crohn’s and Colitis Foundation of America, Robert Wood Johnson Foundation, etc.). Candidates with an active K12 may apply.
• The intent of this award is to foster the scientific independence of junior investigators. It is understood that there may be some overlap with work funded by the mentor, but the goal of this grant is to enable the junior investigator to develop their own research program. It also must be clearly stated that the work submitted by the applicant is primarily that of the applicant, and any work or data from the senior mentor’s laboratory clearly defined.
• Resources allocated through this award are intended to support the career development of the applicant. Accordingly, requests for salary, fringe benefits or other support for the mentor are not allowed. Indirect costs are not allowed. Upon notification of receipt of this award, the recipient must provide institutional approval from the appropriate committee for use of human subjects or animals. If approval is not necessary, the recipient must provide an explanation. Evidence for developing independence in research initiatives should be provided.
• Candidates are required to have a sponsor and preceptor for the award; however, one individual may serve in the capacity of both positions. A sponsor is an individual who takes responsibility for the quality assessment of the proposed research project, the quality of the research environment within which the project will be undertaken, and the experience and expertise of the principal investigator and other key researchers involved. A preceptor will supervise the principal investigator’s research activities and will serve as a mentor.
• Annually, a one-page plain language progress report, a scientific progress report, a financial statement, a list of publications based on the research and a letter of certification from the division chief or department chair, must be submitted by the award recipient by Nov. 30. Second year funding is contingent upon submission of this documentation. All publications, presentations and abstracts arising from work funded by this program must acknowledge support of the AGA-Aptalis Research Award in Pancreatic Disease.
There must be a strong commitment from the candidate’s institution to support the required protected time for research and adequate laboratory space and/or other supporting facilities. These commitments must be outlined in a letter from the candidate’s division chief or department chair. The letter must certify that the award is being used to provide protected time, in accord with the terms of the award. In addition, it is expected that the sponsor will outline specific plans for the future development of the candidate’s research career. The institution must commit to ensuring timely and accurate reporting of the awardee’s current and future research activities at the institution; this is to include an annual report of the funding status, grants submitted and pending, and all publications.
The recipient will be selected based on the following criteria: significance, investigator, innovation, approach, environment, relevance to AGA’s mission and evidence of institutional commitment. The candidate should state clearly how the additional training will benefit his/her research career.
A selection committee comprised of members of the AGA Research Awards Panel will review the proposals and select the award recipients. Funding will commence October 2014.
The application deadline is June 6, 2014. The completed application, letters of support or commitment and other documents, as applicable, must be combined into and submitted as one PDF document. The document must be titled by the applicant’s last name and first initial only. Hard copies are not accepted. Please email the application document to email@example.com. Direct all questions to the research awards manager via telephone at 301-222-4012 or email at firstname.lastname@example.org.
Funding for this award is provided by Aptalis Pharma US, Inc.
Broad Medical Research Program Inflammatory Bowel Disease Grants
Recognizing that some of the most promising research in this area of medicine is at the very early stages of development, the Broad Medical Research Program funds studies and investigation of new ideas in their initial exploratory stage that do not yet qualify for funding from more traditional sources like the National Institutes of Health. By supporting innovative and promising ideas, we hope to advance the research so it is likely to receive continuation funding from other sources. The Broad Medical Research Program awards one- and two-year grants for basic or clinical IBD research projects to qualified investigators from around the world who work in a nonprofit academic organization. Grant applications submitted to the Broad Medical Research Program are not reviewed by a committee. Instead, leading investigators in each research area review proposals and provide suggestions for improvement. Over 1,900 reviewers from 41 countries have participated in the review process. Proposals are selected for funding based on their scientific strength, innovation and relevance to IBD diagnosis, therapy or prevention. To expedite the research, we accept applications year-round and fund approved applications in about three months.Because we believe that great ideas could come from non-traditional sources, we encourage basic and clinical investigators and scientists not currently working in IBD and interdisciplinary teams to apply.Application ProcessThere is a two-step process for requesting funds from the Broad Medical Research Program:1. The first step is to submit a Letter of Interest. Decisions on Letters of Interest are based on external expert review of the proposal and usually are made within four to six weeks. Instructions for Letters of Interest can be found at www.broadmedical.org.2. If we are interested in pursuing a project, an invitation is extended to submit a full grant application. At that time, the grant application instructions and forms are sent to the Principal Investigator. Decisions on grant applications are made based on external review by subject experts and usually take eight to 10 weeks.There are no deadlines or specific dates for applications. Proposals are accepted and reviewed year-round.Proposal Review• Most Letters of Interest and all grant applications will be evaluated by active investigators in the specific research area.• Reviewers are located throughout the world and are chosen carefully not to have conflicts of interest with the applicants.• Grant proposals will be selected for funding based on their scientific strength, innovative value and relevance to IBD diagnosis, therapy or prevention.• Decisions on Letters of Interest will usually be made within 4-6 weeks.• Decisions on grant applications will usually be made within 8-10 weeks.Funding Guidelines• Preference is given to proposals with strong potential of clinical benefit to IBD patients in the foreseeable future.• Funding can be requested for up to two years.• Funding of a second year will be based on an evaluation of the progress and the perceived value of the findings from the first year of funding.
Letter of Interest Submission 1. Direct Letters of Interest to: Daniel Hollander, M.D. Director Broad Medical Research Program The Eli and Edythe Broad Foundation, Scientific | Medical Research 10900 Wilshire Boulevard, Twelfth Floor Los Angeles, California 90024-6532 U.S.A. 2. If possible, please send your Letter of Interest and all attachments electronically to: email@example.com. If you send it electronically, please do not send a printed copy. 3. Receipt of your Letter of Interest will be acknowledged by e-mail within a few days. If you do not hear from us in a timely manner, please contact us at firstname.lastname@example.org to make sure that your letter has been received. 4. You may include suggestions for potential reviewers and also indicate individuals with potential conflicts of interest. Unless required by your institution, Letters of Interest may be submitted directly to the BMRP by the Principal Investigator and do not require institutional approval or signature. 5. Letters of Interest are accepted and reviewed throughout the year; there are no deadlines.